PB1046

PhaseBio gets FDA nod to begin Covid-19 trial with VIP receptor agonist PB1046
Pharmaceutical Business Review
Thu, 05/28/20 - 10:33 am
PhaseBio
clinical trials
PB1046
COVID-19